On July 1, 2024, Masimo Corporation announced that it has sent a letter to shareholders, highlighting independence and medtech experience of its nominee Christopher Chavez and contrasts it to Politan Capital?s handpicked nominees, and the Company believes that ceding control of the Company to Politan Capital by electing its nominees would jeopardize the value of your investment in the Company, and the Company board encouraged stockholders to vote for Company?s director nominees, Joe Kiani and Christopher Chavez, at the 2024 annual meeting of shareholders.